GlassScriptPhysician profile
Hua Zhang
NPI 1730114893
$2,363.81
in general payments reported to CMS, 2019-2025
23 companies · $13.46 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,594 · 2020: $305 · 2021: $169 · 2022: $68.49 · 2023: $214 · 2025: $13.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $361.70 | 2019-2023 | Breztri |
| Novo Nordisk INC | $247.57 | 2019-2025 | Wegovy |
| Lilly USA, LLC | $220.83 | 2019-2021 | |
| Amgen INC. | $190.39 | 2019-2023 | Prolia, Evenity |
| Pfizer INC. | $172.87 | 2019-2020 | |
| Merz North America, INC. | $172.52 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.22 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $136.41 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $132.84 | 2019-2020 | |
| Boston Scientific Corporation | $126.49 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $87.59 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $48.53 | 2019-2020 | |
| Sanofi Pasteur INC. | $38.31 | 2019-2020 | |
| Glaxosmithkline, LLC. | $37.60 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $34.08 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $33.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.37 | 2019 | |
| Sientra, INC. | $29.15 | 2019 | |
| Allergan, INC. | $28.49 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.08 | 2019 | |
| Acerus Pharmaceuticals Corporation | $14.70 | 2021 | |
| Esperion Therapeutics, INC. | $12.05 | 2021 | |
| Orexo US, INC. | $11.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hua Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.